The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Methamphetamine toxicity and messengers of death
Open accessAbstract
Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter and microgliosis in different brain areas. In the present review, we summarize data on the animal models of METH neurotoxicity which include degeneration of monoaminergic terminals and neuronal apoptosis. In addition, we discuss molecular and cellular bases of METH-induced neuropathologies. The accumulated evidence indicates that multiple events, including oxidative stress, excitotoxicity, hyperthermia, neuroinflammatory responses, mitochondrial dysfunction, endoplasmic reticulum stress converge to mediate METH-induced terminal degeneration and neuronal apoptosis. When taken together, these findings suggest that pharmacological strategies geared towards the prevention and treatment of the deleterious effects of this drug will need to attack the various pathways that form the substrates of METH toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–326 of 326
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
WALSH, S. L., & Wagner, G. C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10392-3 · Cited by 87
Brain antioxidant systems in human methamphetamine users
Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Peretti, F. J., Aiken, S. S., Wickham, D. J., Sherwin, A. L., Nóbrega, J. N., Forman, H. J., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02434.x · Cited by 86
Morgan, M. E., & Gibb, J. W. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90010-6 · Cited by 86
Eyerman, D. J., & Yamamoto, B. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04837.x · Cited by 86
α-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex
Commins, D., & Seiden, L. S. (1986) · Brain Research · doi:10.1016/0006-8993(86)90717-1 · Cited by 85
Increased white matter hyperintensities in male methamphetamine abusers
Bae, S. C., Lyoo, I. K., Sung, Y. H., Yoo, J., Chung, A., Yoon, S. J., Kim, D., Hwang, J., Kim, S. J., & Renshaw, P. F. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.016 · Cited by 85
Eyerman, D. J., & Yamamoto, B. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072264 · Cited by 85
Fleckenstein, A. E., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37016-8 · Cited by 84
Neurotoxicity of Endogenous Cysteinylcatechols
Montine, T. J., Picklo, M. J., Amarnath, K., Whetsell, W. O., & Graham, D. G. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6662 · Cited by 83
Numachi, Y., Ohara, A., Yamashita, M., Fukushima, S., Kobayashi, H., Hata, H., Watanabe, H., Hall, F. S., Lesch, K., Murphy, D. L., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.022 · Cited by 83
Malemud, C. J., & Miller, A. H. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.171 · Cited by 82
Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.
Wagner, G. C., Carelli, R. M., & Jarvis, M. F. (1985) · PubMed · Cited by 80
Stone, D. M., Johnson, M., Hanson, G. R., & Gibb, J. W. (1989) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(89)90048-5 · Cited by 80
Free radical production induced by methamphetamine in rat striatal synaptosomes
Pubill, D., Chipana, C., Camins, A., Pallàs, M., Camarasa, J., & Escubedo, E. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.008 · Cited by 80
Melega, W. P., Jorgensen, M. J., Laćan, G., Way, B. M., Pham, J., Morton, G. G., Cho, A. K., & Fairbanks, L. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301502 · Cited by 79
Wang, S., Yen, J., Yin, P., Chi, C., & Lee, H. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.020 · Cited by 79
Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats
Escubedo, E., Guitart, L., Sureda, F. X., Jiménez, A., Pubill, D., Pallàs, M., Camins, A., & Camarasa, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01065-8 · Cited by 79
Shioda, N., Han, F., Moriguchi, S., & Fukunaga, K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04600.x · Cited by 78
Asanuma, M., Tsuji, T., Miyazaki, I., Miyoshi, K., & Ogawa, N. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.015 · Cited by 78
Green, A. R., DeSouza, R. J., WILLIAMS, J., MURRAY, T., & Cross, A. J. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90062-t · Cited by 77
Kanthasamy, A., ANANTHARAM, V., ALI, S. F., & KANTHASAMY, A. G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.022 · Cited by 76
Weihmuller, F. B., O’Dell, S. J., & Marshall, J. F. (1992) · Synapse · doi:10.1002/syn.890110209 · Cited by 76
Xu, W., Zhu, J. P. Q., & Angulo, J. A. (2005) · Synapse · doi:10.1002/syn.20185 · Cited by 75
Açıkgöz, O., Gönenç, S., Kayatekin, B. M., Uysal, N., Pekçetin, Ç., Şemin, İ., & Güre, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01020-8 · Cited by 75
Fornai, F., Lenzi, P., Ferrucci, M., Lazzeri, G., di Poggio, A. B., Natale, G., Busceti, C. L., Biagioni, F., Giusiani, M., Ruggieri, S. A., et al. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.02.022 · Cited by 75
Protein expression profile in the striatum of acute methamphetamine-treated rats
Iwazaki, T., McGregor, I. S., & Matsumoto, I. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.052 · Cited by 74
Cappon, G. D., Pu, C., & Vorhees, C. V. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02107-7 · Cited by 74
Hsu, S.-F., Niu, K., Lin, C.-L., & Lin, M. (2006) · Shock · doi:10.1097/01.shk.0000223124.49265.10 · Cited by 73
Ali, S. F., & Itzhak, Y. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08227.x · Cited by 73
The Contribution of the DNA Damage Response to Neuronal Viability
Barzilai, A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.211 · Cited by 72
Mark, K., Quinton, M. S., Russek, S. J., & Yamamoto, B. K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0013-07.2007 · Cited by 71
Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs
Itzhak, Y., & Ali, S. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.004 · Cited by 71
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse Olfactory Bulb
Deng, X., Ladenheim, B., Jayanthi, S., & Cadet, J. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.010 · Cited by 70
Self-citationDroin, N. M., Pinkoski, M. J., Dejardin, E., & Green, D. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7638-7647.2003 · Cited by 70
Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., Shimizu, E., & Iyo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300512 · Cited by 70
Lin, P.-S., Quamo, S., Ho, K.-C., & Gladding, J. (1991) · Radiation Research · doi:10.2307/3578169 · Cited by 67
Baldwin, H. A., Colado, M. I., Murray, T. K., Souza, R. J. D., & Green, A. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12847.x · Cited by 67
Sim, T., Simon, S. L., Domier, C. P., Richardson, K., Rawson, R. A., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_07 · Cited by 66
Jayanthi, S., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1124 · Cited by 66
Self-citationMethamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity
Stephans, S. E., & Yamamoto, B. K. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00587-0 · Cited by 65
Methamphetamine-induced expression of interleukin-1β mRNA in the rat hypothalamus
Yamaguchi, T., Kuraishi, Y., Minami, M., Nakai, S., Hirai, Y., & Satoh, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90766-m · Cited by 65
Zhu, J. P. Q., Xu, W., & Angulo, J. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.089 · Cited by 64
Potashkin, J. A., & Meredith, G. E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.144 · Cited by 64
Warren, M. W., Kobeissy, F. H., Liu, M. C., Hayes, R. L., Gold, M. S., & Wang, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.058 · Cited by 64
Taylor, M. J., Schweinsburg, B. C., Alhassoon, O. M., Gongvatana, A., Brown, G. G., Casey, C. Y., Letendre, S. L., Grant, I., & the HNRC Group (2007) · Journal of NeuroVirology · doi:10.1080/13550280701194230 · Cited by 64
Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation
Cadet, J. L., & Krasnova, I. N. (2007) · Neurotoxicity Research · doi:10.1007/bf03033915 · Cited by 63
Self-citationKondo, T., Ito, T., & SUGITA, Y. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21807.x · Cited by 63
Itzhak, Y., Martin, J. L., & Ali, S. F. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00022 · Cited by 63
Escubedo, E., Chipana, C., Pérez-Sánchez, M., Camarasa, J., & Pubill, D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089748 · Cited by 63
Methamphetamine selectively alters brain glutathione
Harold, C., Wallace, T. L., Friedman, R., Gudelsky, G. A., & Yamamoto, B. K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00392-7 · Cited by 62
Armstrong, B. D., & Noguchi, K. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.06.003 · Cited by 61
Asanuma, M., Miyazaki, I., Higashi, Y., Tsuji, T., & Ogawa, N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.009 · Cited by 61
Lazzeri, G., Lenzi, P., Busceti, C. L., Ferrucci, M., Falleni, A., Bruno, V., Paparelli, A., & Fornai, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04429.x · Cited by 61
Tata, D. Α., & Yamamoto, B. K. (2008) · Synapse · doi:10.1002/syn.20497 · Cited by 60
Segal, D. S., Kuczenski, R. T., O’Neil, M. L., Melega, W. P., & Cho, A. K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2188-4 · Cited by 60
Zhu, J., Wang, X., Angulo, N., & Angulo, J. A. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.05.014 · Cited by 60
Ricaurte, G. A., Fuller, R. W., Perry, K. W., Seiden, L. S., & Schuster, C. R. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90075-8 · Cited by 59
Persistence of tolerance to methamphetamine-induced monoamine deficits
Danaceau, J. P., Deering‐Rice, C. E., Day, J. E., Smeal, S. J., Johnson‐Davis, K. L., Fleckenstein, A. E., & Wilkins, D. G. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.045 · Cited by 59
Moszczyńska, A., Turenne, S. D., & Kish, S. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00711-3 · Cited by 59
Kitamura, O., Tokunaga, I., Gotohda, T., & Kubo, S. (2006) · International Journal of Legal Medicine · doi:10.1007/s00414-006-0087-9 · Cited by 59
Graham, D. L., Noailles, P.-A. H., & Cadet, J. L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05269.x · Cited by 58
Self-citationMethamphetamine‐induced spectrin proteolysis in the rat striatum
Staszewski, R., & Yamamoto, B. K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03618.x · Cited by 57
Cadet, J. L., Ali, S. F., & EPSTEIN, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21827.x · Cited by 57
Self-citationBroening, H. W., Morford, L. L., & Vorhees, C. V. (2005) · Synapse · doi:10.1002/syn.20130 · Cited by 57
Jeng, W., Ramkissoon, A., Parman, T., & Wells, P. G. (2006) · The FASEB Journal · doi:10.1096/fj.05-5271com · Cited by 57
Li, X., Wang, H., Qiu, P., & Luo, H. L. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.014 · Cited by 57
SHENG, P., Cerruti, C., Ali, S. F., & Cadet, J. L. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17440.x · Cited by 56
Self-citationMemantine protects against amphetamine derivatives-induced neurotoxic damage in rodents
Chipana, C., TORRES, I., Camarasa, J., Pubill, D., & Escubedo, E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.003 · Cited by 56
Luoma, J. I., & Zirpel, L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5227-07.2008 · Cited by 55
He, J., Xu, H., Yang, Y., Zhang, X., & Li, X. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.060 · Cited by 54
Yuan, J., Hatzidimitriou, G., Suthar, P., Mueller, M., McCann, U. D., & Ricaurte, G. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096503 · Cited by 53
Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats
Bittner, S. E., Wagner, G. C., Aigner, T. G., & Seiden, L. S. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90306-3 · Cited by 52
Methamphetamine‐Induced Depression of Monoamine Synthesis in the Rat: Development of Tolerance
Schmidt, C. J., Somalia, P. K., Hanson, G. R., Peat, M. A., & Gibb, J. W. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb12893.x · Cited by 51
Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase
Maragos, W. F., Jakel, R. J., Chesnut, D., Pocernich, C. B., Butterfield, D. A., Clair, D. K. S., & Cass, W. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02707-4 · Cited by 51
Mice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
Deng, X., Jayanthi, S., Ladenheim, B., Krasnova, I. N., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.993 · Cited by 51
Self-citationMethamphetamine Use Trends among Street-Recruited Gay and Bisexual Males, from 1999 to 2007
Reback, C. J., SHOPTAW, S. J., & Grella, C. E. (2008) · Journal of Urban Health · doi:10.1007/s11524-008-9326-3 · Cited by 51
Finnegan, K. T., Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1982) · Psychopharmacology · doi:10.1007/bf00436098 · Cited by 50
Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301119 · Cited by 50
Similarities between Methamphetamine Toxicity and Proteasome Inhibition
Fornai, F., Lenzi, P., Gesi, M., Ferrucci, M., Lazzeri, G., Capobianco, L., Blasi, A. D., Battaglia, G., Nicoletti, F., Ruggieri, S. A., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.021 · Cited by 50
Melega, W. P., La?an, G., DeSalles, A. A. F., & Phelps, M. E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4<243::aid-syn1>3.0.co;2-n · Cited by 50
Farfel, G. M., Vosmer, G. L., & Seiden, L. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91460-v · Cited by 49
Warren, M. W., Zheng, W., Kobeissy, F. H., Liu, M. C., Hayes, R. L., Gold, M. S., Larner, S. F., & Wang, K. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007061 · Cited by 49
Warren, M. W., Larner, S. F., Kobeissy, F. H., Brezing, C., Jeung, J. A., Hayes, R. L., Gold, M. S., & Wang, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0259-9 · Cited by 48
Achat‐Mendes, C., Ali, S. F., & Itzhak, Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300675 · Cited by 48
Tata, D. Α., Raudensky, J., & Yamamoto, B. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05688.x · Cited by 47
Methamphetamine increases basal ganglia iron to levels observed in aging
Melega, W. P., Laćan, G., Harvey, D. C., & Way, B. M. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f0d4f4 · Cited by 47
Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice
Kita, T., Paku, S., Takahashi, M., Kubo, K., Wagner, G. C., & Nakashima, T. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00106-3 · Cited by 47
Schmidt, C. J., & Gibb, J. W. (1985) · Neurochemical Research · doi:10.1007/bf00964403 · Cited by 44
Hom, D. G., Jiang, D., Hong, E., Mo, J. Q., & Andersen, J. K. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00296-3 · Cited by 44
Kadota, T., & Kadota, K. (2004) · Archivum histologicum japonicum · doi:10.1679/aohc.67.241 · Cited by 43
Involvement of dopamine receptor subtypes in mouse thermoregulation
Zarrindast, M., & Tabatabai, S. A. (1992) · Psychopharmacology · doi:10.1007/bf02245159 · Cited by 42
UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia
Sprague, J. E., Mallett, N. M., Rusyniak, D. E., & Mills, E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.049 · Cited by 42
Psychoproteomic Analysis of Rat Cortex Following Acute Methamphetamine Exposure
Kobeissy, F. H., Warren, M. W., Ottens, A. K., Sadasivan, S., Zhang, Z., Gold, M. S., & Wang, K. (2008) · Journal of Proteome Research · doi:10.1021/pr800029h · Cited by 42
Iwashita, A., Mihara, K., Yamazaki, S., Matsuura, S., Ishida, J., Yamamoto, H., Hattori, K., Matsuoka, N., & Mutoh, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068932 · Cited by 42
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity
Johnson‐Davis, K. L., Fleckenstein, A. E., & Wilkins, D. G. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.09.063 · Cited by 41
Kawasaki, T., Ishihara, K., Ago, Y., Nakamura, S., Itoh, S., Baba, A., & Matsuda, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.012 · Cited by 40
Sánchez, V., Zeini, M., Camarero, J., O’Shea, E., Boscá, L., Green, A. R., & Colado, M. I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01714.x · Cited by 39
Cadet, J. L., McCoy, M. T., & Ladenheim, B. (2002) · Synapse · doi:10.1002/syn.10074 · Cited by 39
Self-citationCallahan, B. T., Cord, B. J., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00341.x · Cited by 36
Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice
Imam, S. Z., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., & Ali, S. F. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00139-5 · Cited by 36
Self-citationBarrett, T., Xie, T., Piao, Y., Dillon‐Carter, O., Kargul, G. J., Lim, M. K., Chrest, F. J., Wersto, R. P., Rowley, D. L., Juhaszova, M., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0423 · Cited by 36
Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats
Pubill, D., Verdaguer, E., Sureda, F. X., Camins, A., Pallàs, M., Camarasa, J., & Escubedo, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01949-0 · Cited by 35
Kuhn, D. M., Francescutti, D. M., & Thomas, D. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.026 · Cited by 34
Methamphetamine-induced Apoptosis in a CNS-derived Catecholaminergic Cell Line
Choi, H. J., Yoo, T. M., Chung, S. Y., Yang, J., Kim, J.-I., Ha, E. S., & Hwang, O. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15026-6 · Cited by 33
Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain
Wallace, T. L., Vorhees, C. V., Zemlan, F. P., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00795-9 · Cited by 33
Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion
Kita, T., Wagner, G. C., Philbert, M. A., et al. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160110 · Cited by 32
Wagner, G. C., & WALSH, S. L. (1991) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(91)90008-a · Cited by 32
Johnson‐Davis, K. L., Truong, J. G., Fleckenstein, A. E., & Wilkins, D. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062695 · Cited by 32
The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice
Sánchez, C. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90108-8 · Cited by 31
Local proteins associated with methamphetamine‐induced nigrostriatal dopaminergic neurotoxicity
Liao, P., Kuo, Y., Hsu, H., Cherng, C. G., & Yu, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03346.x · Cited by 30
Straiko, M. M. W., Coolen, L. M., Zemlan, F. P., & Gudelsky, G. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.073 · Cited by 30
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice
Imam, S. Z., Jankovic, J. J., Ali, S. F., SKINNER, J. T., Xie, W., Conneely, O. M., & Le, W. (2005) · The FASEB Journal · doi:10.1096/fj.04-3362com · Cited by 30
Anderson, K. L., & Itzhak, Y. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.021 · Cited by 28
Halladay, A. K., Kusnecov, A. W., Michna, L., Kita, T., Hara, C., & Wagner, G. C. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.930105.x · Cited by 28
Methamphetamine: Putting the Brakes on Speed
Gettig, J. P., Grady, S. E., & Nowosadzka, I. (2006) · The Journal of School Nursing · doi:10.1177/105984050602200202 · Cited by 27
Direct interactions of methamphetamine with the nucleus
Asanuma, M., Hayashi, T., Ordonez, S., Ogawa, N., & Cadet, J. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00128-5 · Cited by 25
Self-citationAndo, K., Johanson, C. E., Seiden, L. S., & Schuster, C. R. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90522-2 · Cited by 22
Pennypacker, K. R., Yang, X., Gordon, M. N., Benkovic, S. A., Miller, D. B., & O'Callaghan, J. P. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00381-x · Cited by 22
Fukui, K., Nakajima, T., Kariyama, H., Kashiba, A., Kato, N., Tohyama, I., & Kimura, H. (1989) · Brain Research · doi:10.1016/0006-8993(89)90562-3 · Cited by 22
Uemura, K., Aki, T., Yamaguchi, K., & Yoshida, K.-I. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02450-5 · Cited by 22
Hydroxyl Radical Formation Following Methamphetamine Administration to Rats
Kita, T., Takahashi, M., Kubo, K., et al. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb00080.x · Cited by 20
Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats
Quinton, M. S., & Yamamoto, B. K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0796-x · Cited by 20
In PC12 Cells Neurotoxicity Induced by Methamphetamine Is Related to Proteasome Inhibition
Lazzeri, G., Lenzi, P., Gesi, M., Ferrucci, M., Fulceri, F., Ruggieri, S. A., Bruno, V., & Fornai, F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.017 · Cited by 17
Fornai, F., Lenzi, P., Capobianco, L., Iacovelli, L., Scarselli, P., Lazzeri, G., & Blasi, A. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05284.x · Cited by 15
O’Dell, S. J., & Marshall, J. F. (2004) · Synapse · doi:10.1002/syn.20098 · Cited by 15
Betts, E. S., Krasnova, I. N., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045453 · Cited by 5
Self-citation
Cited by
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
kappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214
Decreased dopamine activity predicts relapse in methamphetamine abusers
Wang, G. J., Smith, L., Volkow, N. D., Telang, F., Logan, J., Tomasi, D., Wong, C. T., Hoffman, W., Jayne, M., Alia-Klein, N., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.86 · Cited by 214
Metadata
- Authors
- Krasnova, I. N., & Cadet, J. L.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 60
- Issue
- 2
- Pages
- 379-407
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2154345916
- Cited by
- 589
- References
- 326
- FWCI
- 15.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.